HF
NVAX icon

Hoxton Financial’s Novavax NVAX Stock Holding History

Hoxton Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5
Closed -$1K – 370
2015
Q4 		$1K Hold
5
– – ﹤0.01% 304
2015
Q3 		$1K Hold
5
– – ﹤0.01% 316
2015
Q2 		$1K Hold
5
– – ﹤0.01% 321
2015
Q1 		$1K Hold
5
– – ﹤0.01% 310
2014
Q4 		$1K Buy
+5
New +$523 ﹤0.01% 329

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Hoxton Financial's NVAX Position: Q1 2016 in Review

Hoxton Financial sold out of Novavax (NVAX) in Q1 2016, closing a stake of 5 shares — an estimated $1K sold.

Hoxton Financial first reported a position in NVAX in Q4 2014 and held it in 5 quarters. The position peaked at $1K in Q4 2015. 176 funds tracked by Wall St. Rank hold NVAX as of Q1 2016.

  • Hoxton Financial reported no remaining Novavax position as of Q1 2016 after selling out during the quarter.
  • Hoxton Financial sold 5 Novavax shares in Q1 2016, an estimated $1K.
  • Hoxton Financial first reported a position in Novavax in Q4 2014 and held it in 5 quarters.
  • Hoxton Financial's Novavax position peaked at $1K in Q4 2015.
  • 176 funds tracked by Wall St. Rank held Novavax as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.